The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients

Nav

General Info

Geography

China (CHN)

Beijing, Chongqing, Fujian, Guangdong, Guizhou, Hebei, Henan, Hunan, Inner Mongolia, Jiangsu, Jiangxi, Liaoning, Shaanxi, Shandong, Shanghai, Shanxi, Sichuan, Tianjin, Xinjiang, Zhejiang

Time period covered

01/1999 - 12/2004

Data type

Scientific literature

Keywords

Cardiovascular and circulatory diseases, Ischemic heart disease, Stroke

Citation

Authors

Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A, FEVER Study Group

Journal

J Hypertens

Volume

Issue

Pages

2157-72

Publication year

2005

Suggested citation

Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A, FEVER Study Group. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens. 2005; 23(12): 2157-72.

GHDx Entry last modified on: Oct 8, 2022

Header sites

Search form

Main menu

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients

Nav